Prevention of Rh imumunisation post-partum and during the second half of pregnancy;Forebyggelse af rhesusimmunisering: II. Imødegåelse af risiko i sidste halvdel af graviditeten og ved fødslen

Ugeskrift for Laeger

Volumn 166, Issue 36, 2004, Pages 3078-3083

  Falck Larsen, Jørgen ^a   Bock, Johannes E ^a   Jørgensen, Jan R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; RHESUS D ANTIBODY; RHESUS D ANTIGEN;

ABDOMINAL INJURY; AMNIOCENTESIS; CORDOCENTESIS; DRUG INDICATION; FETOMATERNAL TRANSFUSION; HUMAN; IMMUNOPROPHYLAXIS; PREGNANCY; REVIEW; RHESUS ISOIMMUNIZATION;

FEMALE; FETOMATERNAL TRANSFUSION; HUMANS; POSTPARTUM PERIOD; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PUERPERAL DISORDERS; RH ISOIMMUNIZATION; RHO(D) IMMUNE GLOBULIN; RISK FACTORS;

EID: 4444342972     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Falck Larsen J, Bock JE, Jørgensen J. Forebyggelse af rhesus-immunisering. I. Teoretisk baggrund og imødegåelse af risiko i første del af graviditeten. Ugeskr Læger 2004;166:3073-8.
2. Bowman JM, Pollock JM, Penston LE. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang 1986;51:117-21.
3. Bowman JM. The prevention of Rh immunization. Transfus Med Rev 1988;2:129-50.
4. Crowther C, Middleton P. Anti-D administration after childbirth for preventing Rhesus alloimmunisation (Cochrane review). I: The Cochrane Library, Issue 2, 2004. Chichester: John Wiley & sons.
5. Royal College of Obstetricians and Gynaecologists. Use of Anti-D Immunoglobulin for Rh profylaxis. Green Top Guidelines. Revised May 2002. www.rcog.org.uk/guidelines/maj 2004.
6. National Institute for Clinical Excellence, U. K. Guidance on the use of routine antenatal anti-D profylaxis for RhD-negative women. Technical Appraisal No. 41. May 2002. www.nice.org.uk/maj 2004.
7. American College of Obstetrics and Gynecology. Clinical management guidelines for obstetrician-gynecologists. ACOG practice bulletin. Prevention of Rh D alloimmunization. Int J Gynaecol Obstet 1999;66:63-70.
8. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy. BMJ 1974;2:75-80.
9. Davey MG, Zipursky A. McMaster conference on prevention of Rh immunization. Vox Sang 1979;36:50-64.
10. Pollack W, Ascari WQ, Kochesky RJ et al. Studies on Rh prochylaxis. 1. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion 1971;11:333-9.
11. Contreras M. The prevention of Rh haemolytic disease of the fetus and newborn-general background. Br J Obstet Gynecol 1998;105(suppl 18):7-10.
12. Zipursky A. Rh hemolytic disease of the newborn - the disease eradicated by immunology. Clin Obstet Gynecol 1977;20:759-72.
13. Ness PM, Baldwin ML, Niebyl JR. Clinical high-risk designation does not predict excess fetal-maternal hemorrhage. Am J Obstet Gynecol 1987;156:154-8.
14. Bowman JM, Chewn B, Lewis M et al. Rh isoimmunization during pregnancy: antenatal prophylaxis. Can Med Assoc J 1978;118:623-7.
15. Trolle B. Prenatal Rh-immune prophylaxis with 30C micrograms immune globulin anti-D in the 28th week of pregnancy. Acta Obstet Gynecol Scand 1989;68:45-7.
16. Tovey LA, Townley A, Stevenson BJ et al. The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae. Lancet 1983;2:244-6.
17. Lee D, Rawlinson VI. Multicentre trial of antepartum low-dose anti-D immunoglobulin. Transfus Med 1995;5:15-9.
18. Huchet J, Dallemagne S, Huchet C et al. Application anté-partum du traitement préventif d'immunisation Rhésus D chez les femmes Rhésus négatif. J Gynecol Obstet Biol Reprod (Paris) 1987;16:101-11.
19. Consensus Conference on Anti-D Prophylaxis. Br J Obstet Gynaecol 1998;105(suppl 18):iv, 1-44.
20. Crowther C. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation (Cochrane Review). I: The Cochrane Library, Issue 2, 2004. Chichester: John Wiley & sons.
21. Fung K, Fung K, Eason E et al. Prevention of Rh alloimmunization. J Obstet Gynaecol Can 2003;25:765-73.
22. Owen J, Stedman CM, Tucker TL. Comparison of predelivery versus post-delivery Kleihauer-Betke stains in cases of fetal death. Am J Obstet Gynecol 1989;161:663-6.
23. Laube DW, Schauberger CW. Fetomaternal bleeding as a cause for "unexplained" fetal death. Obstet Gynecol 1982;60:649-51.
24. Goodwin TM, Breen MT. Pregnancy outcome and fetomaternal hemorrhage after noncatastrophic trauma. Am J Obstet Gynecol 1990;162:665-71.
25. Blajchman MA, Maudsley RF, Uchida I et al. Diagnostic amniocentesis and fetal-maternal bleeding. Lancet 1974;1:993-4.
26. Jørgensen, J. Foeto-maternel blødning [disputats]. Århus: Eget forlag, 1976.
27. Weiner C, Grant S, Hudson J et al. Effect of diagnostic and therapeutic cordocentesis on maternal serum alpha-fetoprotein concentration. Am J Obstet Gynecol 1989;161:706-8.
28. Gjøde P, Rasmussen TB, Jørgensen J. Fetomaternal bleeding during attempts at external version. Br J Obstet Gynaecol 1980;87:571-3.
29. Marcus RG, Crewe-Brown H, Krawitz S et al. Feto-maternal haemorrhage following successful and unsuccessful attempts at external cephalic version. Br J Obstet Gynaecol 1975;82:578-80.
30. Vos GH. The effect of external version on antenatal immunization by the Rh factor. Vox Sang 1967;12:390-6.
31. Salama A, David M, Wittmann G et al. Use of the gel agglutination technique for determination of fetomaternal hemorrhage. Transfusion 1998;38:177-80.
32. Kumpel BM, Labeling D. Flow cytometric BM, cytometric quantification of fetomaternal hemorrhage after the RBCs have been coated with anti-D. Transfusion 2001;41:1059-63.
33. Hermann M, Kjellman H, Ljunggren C. Antenatal prophylaxis of Rh immunization with 250 micrograms anti-D immunoglobulin. Acta Obstet Gynecol Scand Suppl 1984;124:1-15.
34. Maayan-Metzger A, Schwartz T, Sulkes J et al. Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis. Arch Dis Child Fetal Neonatal Ed 2001;84:F60-2.
35. ScHARR Rapid Review Group University of Sheffield. A review of the clinical effectiveness and cost effectiveness of routine anti-D profylaxis for pregnant women who are rhesus (rhD) negative 2002. www.nice.com.uk/maj 2004.